On Saturday 9 October, the Daily Mail ran a piece from One Cancer Voice urging the government to commit much-needed funding to improve and maintain cancer services. KCSN was one of the 47 cancer charities lobbying for this change. COVID-19 has impacted cancer services and halted progress, delaying both diagnosis and treatment. Although most services […]
Studies have shown that people who are immunosuppressed – around 500,000 people in the UK – are unlikely to mount a strong defence against COVID-19, even after two doses of vaccine: UK vaccine booster scheme likely to start in September Do I need a booster? On 1 September, the Joint Committee on Vaccination and Immunisation […]
This year there was some very important data presented at the ESMO 2021 virtual meeting regarding COVID-19 and cancer. We have been dealing with this pandemic for a long time, and researchers have been working hard to generate data that can inform clinical decisions regarding the outcomes and risk factors in patients with cancer and […]
The latest findings from five studies presented at the ESMO Congress 2021 help cut short the debate on the safety and efficacy of COVID vaccines in cancer patients and re-affirm ESMO’s recommendations for early vaccination of this high-priority population, as outlined in the ESMO ten statements, which were updated in April 2021. Patients with cancer or a history […]
Following expert clinical advice, the government is ending the requirement for shielding guidance for people considered to be clinically extremely vulnerable. Clinically extremely vulnerable people will not be advised to shield again, but might wish to take extra precautions to keep themselves safe, especially in areas of the country with high rates of infection. Read […]
A recent review published in the Journal for ImmunoTherapy of Cancer looks at the implications of people with renal cell carcinoma (RCC) taking immune checkpoint inhibitors and contracting the SARS-CoV-2 virus. Cancer patients are considered at high risk during the coronavirus pandemic. However, this review states that, although additional studies are needed, the most up-to-date […]
Forty (40) charities and organisations have written an open letter, urging the public to help keep vulnerable people safe as restrictions ease. Rose Woodward, Founder and Patient Advocate of KCSN, was one of those who endorsed this letter. The letter was published in The Guardian yesterday: Here is the letter in full: Tomorrow in England […]
The Joint Committee on Vaccination and immunisation (JVCI) have given interim advice on who to prioritise for a third dose of the COVID-19 booster vaccine from September. Millions of the most vulnerable people to COVID-19 may be offered the booster vaccination to ensure they have protection through the winter against new coronavirus variants. The JVCI’s […]
The pharmaceutical industry is dedicated to developing effective vaccines that benefit people’s health, the economy and society. Vaccination has saved more lives and prevented more serious diseases than any other advance in recent medical history. It has also enabled the economy to thrive and reduced the burden on the NHS. COVID-19 has shone a spotlight […]
Following suspensions by some countries of the COVID-19 Oxford AstraZeneca COVID-19 vaccine over suspected blood clots, the Medicines and Healthcare Regulatory Authority (MHRA) in the UK confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go and get their COVID-19 vaccine when asked to do so. Read […]
Copyright 2017 Kidney Cancer Support Network- Douglass Digital | Cambridge Web Design
